Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
The Bell Global Emerging Companies Fund returned 0.6% in Q2 2026, underperforming the MSCI World SMID Cap Index which rose 11.4%, as momentum-driven markets continued to favor cyclical value and speculative areas over quality. The fund's Quality...
— Ned Bell, Joel Connell, Matt Saddington
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Organo Corporation
No other institutional pitches found for this ticker yet.